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This review proposes a critical discussion of the latest studies investigating the presence
of alexithymia in patients with ﬁbromyalgia (FM) and its relation to other psychological
disorders. The focus is on the most relevant literature exploring the relationship between
FM, a chronic pain syndrome, and alexithymia, an affective dysregulation, largely observed
in psychosomatic diseases.The articles were selected from theMedline/Pubmed database
using the search terms “Fibromyalgia,” “Alexithymia,” and “Psychological Distress.” Of the
seven studies fulﬁlling these criteria, one found no differences between FM patients and
the control group, four found signiﬁcant differences, with higher levels of alexithymia in the
FM sample, while two showed unclear results. Overall, the majority of ﬁndings highlighted
the high prevalence of alexithymia in FM patients. Future studies should clarify the role of
alexithymia in FM, paying attention to two principal aspects: the use, as a control group,
of patients with chronic pain conditions but a low psychosomatic component, and the
use of other measures, in addition to the Toronto Alexithymia Scale (TAS-20), to assess
alexithymia.
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INTRODUCTION
The main aim of this review is to propose a critical discussion of
themost recent studies investigating the presence of alexithymia in
patients affected by ﬁbromyalgia (FM) syndrome, and its relation
to psychological disorders, frequently observed in these patients.
Fibromyalgia is a chronic syndrome characterized by
widespread musculoskeletal pain, with an unknown etiology
(Wolfe et al., 2010), while alexithymia is an affective dysregulation,
characterized by difﬁculties in identifying and communicating
feelings, and externally oriented thinking (Taylor, 1984).
Using the keywords “Fibromyalgia,” “Alexithymia,” and
“Psychological Distress,” the Medline/Pubmed database was
searched for studies examining the prevalence of alexithymia
in FM patients published up to October 2012 which were
then analyzed. In particular, target articles were searched
using the following associations: ﬁbromyalgia AND alexithymia,
ﬁbromyalgia AND psychological distress, ﬁbromyalgia AND alex-
ithymia AND psychological distress. Abstracts were checked and
reviews, comments, and studies not concerning the relationship
betweenﬁbromyalgia, alexithymia, andpsychological distresswere
excluded. Seven studies were ultimately included in this review.
FIBROMYALGIA SYNDROME
Fibromyalgia is a syndrome characterized by chronic, widespread
musculoskeletal pain with tenderness over speciﬁc trigger points
(Mease, 2005; Mease et al., 2009). Its prevalence is estimated to be
between 3 and 6%of theworld population (WHO,2008), predom-
inantly in women, with a female to male ratio of 10:1 (Macfarlane
et al., 1999; Anderberg et al., 2000). It is most commonly diag-
nosed between the ages of 20 and 50, though onset can occur in
childhood.
Fibromyalgia symptoms are not restricted to pain, but often
include a heterogeneous series of other conditions, such as
hyperalgesia and/or allodynia, physical and mental fatigue, dis-
rupted or non-restorative sleep, headaches, irritable bowels,
cognitive impairments, and other functional complaints (Mease,
2005), in the absence of laboratory or radiologic examinations
to support them (Abeles et al., 2007). The etiology of this syn-
drome is not completely understood, but clinicians and researchers
believe that it could result from different factors, such as stress,
medical illness, pain conditions, and a variety of neurotransmit-
ter and neuroendocrine disturbances (Mease, 2005).In particular,
high levels of stress and psychiatric symptoms may negatively
inﬂuence the perception of disease severity (Hawley et al., 1988),
functional ability (Ledingham et al., 1993), and pain threshold
and tolerance (Epstein et al., 1995). Some authors suggest that
the development of FM might stem from stress-induced disrup-
tion of the hypothalamic-pituitary-adrenal (HPA) axis (McBeth
et al., 2005). Exposure to prolonged stressful conditions can
indeed alter the function of the HPA axis, with consequent
increased production of the corticotrophin-releasing factor (CRF)
and a potentially ampliﬁed pain perception. For this reason,
FM is often deﬁned a “central sensitization syndrome,” caused by
increased sensitivity in the central nervous system to pain signals
(Ngian et al., 2011).
Depressive and anxiety disorders (Fietta et al., 2007), as well as
elevated levels of alexithymia (Sayar et al., 2004; Pedrosa-Gil et al.,
2008; Huber et al., 2009; Castelli et al., 2012), have been reported,
among psychological factors, as features largely present in FM
syndrome.
ALEXITHYMIA
Alexithymia is a personality dimension characterized by differ-
ent cognitive and emotional features, observed in many clinical
conditions, especially in psychosomatic disorders (Taylor, 2000).
Sifneos (1972) coined the term alexithymia, literally “absence of
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words for emotion,” to describe people who lack the ability to
communicate their feelings or have limited imagination (Lesser,
1985). The main aspects of alexithymia, which can be considered a
deﬁcit in cognitive processing and emotions regulation (Kooiman
et al., 2004), are a difﬁculty in identifying and describing sub-
jective feelings, a difﬁculty distinguishing between feelings and
the bodily sensations of emotional arousal, restricted imagination
processes, as evidenced by a lack of imagination, and a stimulus-
bound, externally oriented cognitive style (Taylor et al., 1997).
Alexithymic individuals are therefore incapable of adequately
identifying physical sensations such as the somatic manifesta-
tions of emotions and may tend to misinterpret their emotional
arousal as signs of disease (Lumley et al., 1996). This makes
them susceptible to incorrectly attributing emotion-related phys-
ical symptoms to physical disease and to seeking medical care
for symptoms for which no medical explanations can be found
(Tuzer et al., 2011).
The presence of alexithymic traits can be assessed with dif-
ferent instruments such as observer-rated measures, including
the Observer Alexithymia Scale (Haviland et al., 2000) and the
Toronto Structured interview for Alexithymia (Bagby et al., 2006),
or self-report measures, including the Levels of Emotional Aware-
ness Scale (LEAS; Lane and Schwartz, 1987) to evaluate written
emotional response, or the 20-item Toronto Alexithymia Scale
(TAS-20; Bagby et al., 1994a,b).
Of these different instruments, the TAS-20 is one of the most
commonly used by clinicians and researchers, and was the princi-
palmethod employed to assess alexithymia in the studies analyzed.
It provides investigators with a reliable, validated, and common
metric for measuring the construct (Taylor and Bagby, 2004;
Lumley et al., 2007). The TAS-20 consists of three subscales: dif-
ﬁculty identifying feelings (F1), which measures the inability to
distinguish between speciﬁc emotions, or between emotions and
thebodily sensations of emotional arousal; difﬁculty describing feel-
ings (F2), which assesses the inability to verbalize one’s emotions
to others; and externally oriented thinking (F3), which evaluates
the tendency of individuals to focus their attention externally and
not on the inner emotional experience (Taylor and Bagby, 2004;
Lumley et al., 2007).
FIBROMYALGIA SYNDROME AND ALEXITHYMIA
Psychiatric disorders and psychological distress are some of the
predominant features of FM, which may contribute to the man-
ifestation, retention, and intensiﬁcation of the symptomatology
(Fietta et al., 2007; Aguglia et al., 2011).
Among the psychological factors, alexithymia is a personality
construct which has been minimally explored in FM but is worth
examining, as it can interfere with the perception of emotional
sensations.
The inability to emotionally regulate, especially negative feel-
ings, is thought to result in increased negative affects, chronic
sympathetic hyperarousal, and impaired immune status, which
can lead to the development or exacerbation of somatic disease
and pain (Lumley et al., 1996; Huber et al., 2009). On the other
hand, alexithymia could promote maladaptive illness behaviors,
deﬁned as a patient’s ideas, affects, attitudes, and behaviors in rela-
tion to illness and the sick role, since alexithymic individuals may
focus on, amplify, or overreact to unpleasant physical sensations
(Pilowsky and Katsikitis, 1994).
To date, different studies have investigated the presence of alex-
ithymia in FM patients, using distinct experimental procedures.
Of the seven studies selected for the current review, three assessed
alexithymia rates comparing FM patients to patients with other
chronic pain conditions, one compared alexithymia levels com-
paring FM patients to healthy controls and three evaluated the
prevalence of alexithymia comparing FM patients’ values to nor-
mative data from healthy populations. In all these studies, the
assessment of alexithymia was based on the use of TAS-20 (see
Table 1).
The studies listed in the table obtained, at least in part, distinct
results. In particular, one study did not ﬁnd differences between
FM patients and the control group (Malt et al., 2002), four found
signiﬁcant differences (Sayar et al., 2004; Pedrosa-Gil et al., 2008;
Huber et al., 2009; Castelli et al., 2012), and two found unclear
results (Steinweg et al., 2011; Tuzer et al., 2011).
Malt et al. (2002) found no differences in alexithymia scores in
a group of 42 female FM patients compared with an age-matched
random sample of female healthy controls and did not report data
on different subscales scores of TAS-20. A high positive correlation
was detected between alexithymia scores and scores for anxiety,
depression, and neuroticism, allowing the authors to suppose that
alexithymia could be associated with psychological distress.
On the other hand, Sayar et al. (2004), found signiﬁcantly
higher alexithymia scores and more difﬁculties in identifying feel-
ings among FM patients with respect to rheumatoid arthritis
patients or healthy controls. Moreover, the rate of alexithymia
did not change when the severity of pain or the level of depres-
sion were controlled for FM patients, showing that alexithymia
in the FM sample examined was independent of depression
or pain. Pedrosa-Gil et al. (2008) also found a higher preva-
lence of alexithymia in a sample of female FM patients (15%)
compared to values observed in non-clinical populations (7.9%;
Posse et al., 2002). In addition, they highlighted the presence of
a possible relation between dysfunctional emotional regulation,
the core feature of alexithymia, and problematic early relation-
ships in the parental bonding process in FM patients. Whereas
Huber et al. (2009) found that a signiﬁcant difference was present
between the sample of female FM patients recruited and the Ital-
ian healthy normative data (see Bressi et al., 1996), but only on the
“difﬁculty identifying feeling” (DIF) subscale of the TAS-20. In
addition, alexithymia – the DIF subscale in particular – was asso-
ciated with increased affective pain and hypochondriacal illness
behavior.
In line with other evidence (Lumley et al., 1996, 2007), the
authors considered the former relationship to be the result of an
excessive focus of alexithymics on their body or a tendency to mis-
interpret bodily sensations of emotional arousal as symptoms of
physical illness and thought it could be mediated by psycholog-
ical distress and illness behavior. Similarly, Castelli et al. (2012)
reported a higher prevalence of alexithymia in a female FM sam-
ple (20%) with respect to the general population (see above);
in this case, too, the difference was mainly due to difﬁculties in
identifying feelings in FM patients, whereas the other subcompo-
nents of the TAS-20, “difﬁculty describing feeling” and “externally
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Table 1 | Examined studies concerning the multivariate relationship between FM syndrome and alexithymia (TAS-20).
Study Subjects Results
Patients with other chronic pain conditions as control group (three studies)
Sayar et al. (2004) 50 FM patients
20 rheumatoid arthritis patients
42 healthy controls
Signiﬁcant higher alexithymia scores (total and factor 1 scores) in FM compared to both
control groups.
Steinweg et al. (2011) 48 FM patients
36 general medicine patients
43 rheumatoid arthritis patients
44% of alexithymia in FM group vs. 8% in general medicine group and 21% in rheumatoid
arthritis group. Alexithymia was strongly associated with moderate to severe depression.
Tuzer et al. (2011) 70 FM patients
56 chronic low back pain (CLBP)
patients
72 healthy controls
Signiﬁcant higher alexithymia scores in FM sample compared to both CLBP and healthy
control groups.
Healthy controls (one study)
Malt et al. (2002) 42 FM patients
48 healthy controls
No differences in alexithymia scores between FM group and healthy controls.
No control group (three studies)
Pedrosa-Gil et al. (2008) 40 FM patients 15% of alexithymia in FM group.
Huber et al. (2009) 68 FM patients Signiﬁcant differences only on the 1 factor of TAS-20.
Castelli et al. (2012) 55 FM patients 20% of alexithymia in FM group.
oriented thinking,”were not signiﬁcantly different fromnormative
data.
Of the three studies that enrolled a sample of patients affected
by chronic pain conditions, without a psychosomatic component
[i.e., rheumatoid arthritis and chronic low back pain (CLBP)],
Steinweg et al. (2011) found that the prevalence of alexithymia
in FM patients was signiﬁcantly higher than in either the gen-
eral medicine group or the rheumatoid arthritis group. However,
the higher level of alexithymia seen in the FM sample appeared
only after the presence of moderate to severe depression, since
the differences in alexithymia scores became insigniﬁcant when
corrected for depression rate. Likewise, Tuzer et al. (2011) found
that alexithymia, as well as somatization, depression, anxiety, and
hostility, was signiﬁcantly higher in a female FM sample compared
with a CLBP group or healthy control group. Yet considering that
difﬁculty in identifying and describing feelings reciprocally pre-
dicted depression and anxiety symptoms in the study, it is not
clear whether alexithymia is a secondary defensive reaction against
negative affects or a personality trait related to emotional trauma
in women (Lumley and Sielky, 2000; De Gucht and Heiser, 2003).
The results, at least partially contrasting, obtained in the studies
mentioned above, might depend on different reasons. One could
be related to the substantial individual differences in pain severity
and disability in patients with persistent pain (Sayar et al., 2004).
In most cases, pain in FM is rated as more severe than in other
chronic pain conditions (Walter et al., 1998). It is therefore impor-
tant to compare FM patients with other chronic pain groups, after
controlling for pain severity, since the differences in alexithymia
levels may be inﬂuenced by variations in the experience of pain
and disability (Lumley et al., 2002).
Another possible reason could be the exclusive use of the
TAS-20 for the assessment of alexithymia. In recent years, this
instrument has been criticized for its inability to detect the most
severe cases of alexithymia, the difﬁculty in replicating its fac-
tor structure, and its association with negative affectivity (Lane
et al., 1996; Kooiman et al., 2002; Baiardini et al., 2011). Further-
more, the use of explicit self-reports as an exclusive measure
to assess alexithymia has been questioned. Explicit self-reports
require respondents to be aware of their lack of emotional aware-
ness and reduced capacity to describe and identifying feelings
(Parling et al., 2010). A better way to understand the construct
could be the parallel use of a performance-based instrument (see
for example the LEAS; Lane et al., 1990) or a structured interview,
where individuals are not required to assess their own emotional
abilities alone and the examiner determines the appropriate levels
of emotional awareness through their descriptions (Baeza-Velasco
et al., 2012).
ALEXITHYMIA AND PSYCHOLOGICAL DISTRESS IN
FIBROMYALGIA SYNDROME
The presence of psychological distress, especially depression and
anxiety, is a well-known aspect of FM syndrome and has been
reported in many studies (Fietta et al., 2007). At the same time, the
increased prevalence of alexithymia in patients with depression
is now well-established (Honkalampi et al., 2000). It is therefore
important to clarify whether or not the prevalence of alexithymia
in FM patients can be accounted for simply by the presence of
depressive symptoms. In the studies discussed above, the role
of psychological distress, in particular depression, is highlighted
in mediating the relationship between FM and alexithymia. As
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mentioned before, Steinweg et al. (2011) found that the higher
levels of alexithymia seen in FM patients were due only to the
presence of moderate to severe depression, since the differences
in alexithymia scores became insigniﬁcant when controlled for
depression rate. On the other hand, Castelli et al. (2012), study-
ing the quality of life in FM patients found, in both regression
analyses performed, that when the psychological distress vari-
ables were added as competing predictors, alexithymia ceased
to be signiﬁcant in explaining the health-related quality of life
variance. A possible interpretation, given by the authors, is that
the inability of individuals with high degrees of alexithymia to
identify accurately their own feelings limits not only their abil-
ity to regulate their emotions, but also verbal communication
of psychological distress, with a potentially negative impact on
depression and anxiety levels (Taylor et al., 1997). Similarly, inves-
tigating the types of causal attributions in women with chronic
pain, Tuzer et al. (2011) found that the signiﬁcant relationship
between alexithymia scores, the number of somatic symptoms,
and psychological attributions, in the FM group, became insignif-
icant when the effects of psychological distress variables were
controlled for. In other words, the former association appeared to
be caused simply by the effects of depression and anxiety on the FM
patients.
These results reveal the strong link between alexithymia and
psychological distress in FM syndrome, especially depression.
So it is essential for further research to consider the impact of
alexithymia trait and its possible relationship with psychological
distress and psychiatric disorders.
CONCLUSION
Fibromyalgia is amultifaceted condition inwhichmany factors are
involved in the onset and retention of the disease. Psychological
features are some of the principal aspects that contribute to the
disability caused by this pathology and it is therefore essential
to investigate them. Alexithymia is an emotional dysregulation
trait, largely observed in psychosomatic disorders (Taylor, 2000)
that could play an important role in FM syndrome. Alexithymic
individuals are, in fact, incapable of adequately identifyingphysical
sensations such as the somaticmanifestations of emotions andmay
tend to misinterpret their emotional arousal as signs of disease
(Lumley et al., 1996). This could amplify the perception of disease,
bringing patients to seek medical care for symptoms for which
there is no medical explanation.
The available studies show the high prevalence of alexithymic
traits in FM patients, ranging from 15 to 20% (Pedrosa-Gil
et al., 2008; Castelli et al., 2012). However, the unclear results
found in some of these works indicate a need to shed light
on the intensity and unambiguousness of this relationship. As
mentioned before, there are two possible strategies for reaching
this goal. One could be to use a performance-based instrument
(see for example the LEAS; Lane et al., 1990) or a structured
interview, in addition to commonly employed self-report mea-
sures (such as the TAS-20), for the assessment of alexithymia.
The use of explicit self-reports requires, in fact, the respon-
dents to be aware of their emotional dysregulation (Parling
et al., 2010). The use of a performance-based instrument or a
structured interview could represent a step forward toward a
better understanding of this phenomena (Baeza-Velasco et al.,
2012).
The other possibility is to use a control group of patients with
chronic pain conditions with a low psychosomatic component
(such as rheumatoid arthritis patients). The differences observed
in alexithymia levels may be inﬂuenced by variations in the expe-
rience of pain, usually rated as more severe in FM syndrome than
in other chronic pain diseases (Walter et al., 1998). So to bet-
ter understand the prevalence of this psychological dimension
in FM syndrome, it is important to compare FM patients with
other chronic pain groups, after controlling for pain severity. An
additional issue for further studies would be to analyze potential
differences in the evolution of FM syndrome, with reference to the
presence or absence of alexithymia. Speciﬁcally, it would be useful
to investigate whether and how alexithymia inﬂuences the psy-
chopathological symptoms, and the compliance to psychological
and psychopharmacological interventions. Clarifying the role of
alexithymia in FM can thus allow better understanding of the dis-
ease etiology and the development of patient-tailored treatments,
in which both physical and psychological symptoms have to be
considered.
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